NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m5C‐dependent manner
Authors:
- 27 February 2024
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 63 (5) , 962-976
Abstract
It is well known that 5‐methylcytosine (m5C) is involved in variety of crucial biological processes in cancers. However, its biological roles in lung adenocarcinoma (LAUD) remain to be determined. The LUAD samples were used to assess the clinical value of NOP2/Sun RNA Methyltransferase 2 (NSUN2). Dot blot was used to determine global m5C levels. ChIP and dual‐luciferase assays were performed to investigate the MYC‐associated zinc finger protein (MAZ)‐binding sites in NSUN2 promoter. RNA‐seq was used to explore the downstream molecular mechanisms of NSUN2. Dual luciferase reporter assay, m5C‐RIP‐qPCR, and mRNA stability assay were conducted to explore the effect of NSUN2‐depletion on target genes. Cell viability, transwell, and xenograft mouse model were designed to demonstrate the characteristic of NSUN2 in promoting LUAD progression. The m5C methyltransferase NSUN2 was highly expressed and caused elevated m5C methylation in LUAD samples. Mechanistically, MAZ positively regulated the transcription of NSUN2 and was related to poor survival of LUAD patients. Silencing NSUN2 decreased the global m5C levels, suppressed proliferation, migration and invasion, and inhibited activation of PI3K‐AKT signaling in A549 and SPAC‐1 cells. Phosphoinositide‐3‐Kinase Regulatory Subunit 2 (PIK3R2) was upregulated by NSUN2‐mediated m5C methylation by enhancing its mRNA stabilization and activated the phosphorylation of the PI3K‐AKT signaling. The present study explored the underlying mechanism and biological function of NSUN2‐meditated m5C RNA methylation in LUAD. NSUN2 was discovered to facilitate the malignancy progression of LUAD through regulating m5C modifications to stabilize PIK3R2 activating the PI3K‐AKT signaling, suggesting that NSUN2 could be a novel biomarker and promising therapeutic target for LUAD patients.Keywords
Funding Information
- National Natural Science Foundation of China (82173563)
This publication has 58 references indexed in Scilit:
- Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1α-METTL3-m6A/CDK2AP2 axisJournal of Hazardous Materials, 2023
- Genetic variants in RNA m5C modification genes associated with survival and chemotherapy efficacy of colorectal cancerCancer Medicine, 2022
- Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast CancerDrugs, 2020
- MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT PathwayClinical Lung Cancer, 2016
- NSun2-Mediated Cytosine-5 Methylation of Vault Noncoding RNA Determines Its Processing into Regulatory Small RNAsCell Reports, 2013
- The prostate cancer-up-regulated myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptorMedical Oncology, 2013
- Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2Molecular and Cellular Biochemistry, 2011
- The RNA Methyltransferase Misu (NSun2) Mediates Myc-Induced Proliferation and Is Upregulated in TumorsCurrent Biology, 2006
- The nucleotide sequence of methionine elongator tRNA from wheat germBiochemical and Biophysical Research Communications, 1983
- Methylation of yeast tRNAPhe by enzymes from cytoplasm, chloroplasts and mitochondria of Phaseolus vulgarisBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1978